Table 3.

Summary of TEAEs according to severity of anxiety symptoms at baseline (all treated patients).

TEAEs occurring in >5% of patients in either group, n (%)	Severity of anxiety symptoms at baseline
	Mild/moderate (GAD-7 ⩽ 14) (n = 93)	Severe (GAD-7 ⩾ 15) (n = 126)
Nausea	20 (21.5)	44 (34.9)
Headache	11 (11.8)	15 (11.9)
Insomnia	9 (9.7)	11 (8.7)
Nasopharyngitis	7 (7.5)	8 (6.3)
Constipation	6 (6.5)	4 (3.2)
Anxiety	4 (4.3)	10 (7.9)
Dizziness	3 (3.2)	10 (7.9)

GAD-7, Generalized Anxiety Disorder 7-item; TEAE, treatment-emergent adverse event.